Beijing Strong BiotechnologiesInc Future Growth
Future criteria checks 3/6
Beijing Strong BiotechnologiesInc is forecast to grow earnings and revenue by 23.2% and 19.8% per annum respectively. EPS is expected to grow by 23% per annum. Return on equity is forecast to be 15.6% in 3 years.
Key information
23.2%
Earnings growth rate
23.0%
EPS growth rate
Biotechs earnings growth | 43.3% |
Revenue growth rate | 19.8% |
Future return on equity | 15.6% |
Analyst coverage | Low |
Last updated | 30 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,826 | 912 | N/A | 782 | 2 |
12/31/2025 | 2,437 | 763 | N/A | 555 | 2 |
12/31/2024 | 2,056 | 619 | N/A | 388 | 2 |
9/30/2024 | 1,745 | 526 | 524 | 621 | N/A |
6/30/2024 | 1,747 | 533 | 521 | 640 | N/A |
3/31/2024 | 1,762 | 533 | 436 | 589 | N/A |
12/31/2023 | 1,742 | 524 | 437 | 585 | N/A |
9/30/2023 | 1,622 | 491 | 375 | 506 | N/A |
6/30/2023 | 1,615 | 468 | 297 | 420 | N/A |
3/31/2023 | 1,512 | 402 | 299 | 397 | N/A |
12/31/2022 | 1,511 | 389 | 300 | 396 | N/A |
9/30/2022 | 1,504 | 364 | 313 | 426 | N/A |
6/30/2022 | 1,504 | 347 | 304 | 402 | N/A |
3/31/2022 | 1,598 | 392 | 280 | 372 | N/A |
1/1/2022 | 1,599 | 406 | 276 | 341 | N/A |
9/30/2021 | 1,539 | 335 | 244 | 275 | N/A |
6/30/2021 | 1,391 | 299 | 193 | 218 | N/A |
3/31/2021 | 1,109 | 212 | 112 | 132 | N/A |
12/31/2020 | 848 | 112 | 106 | 123 | N/A |
9/30/2020 | 797 | 202 | 80 | 119 | N/A |
6/30/2020 | 752 | 234 | 67 | 115 | N/A |
3/31/2020 | 781 | 284 | 106 | 154 | N/A |
12/31/2019 | 841 | 332 | 127 | 189 | N/A |
9/30/2019 | 813 | 324 | 134 | 194 | N/A |
6/30/2019 | 787 | 318 | 171 | 247 | N/A |
3/31/2019 | 783 | 303 | 162 | 239 | N/A |
12/31/2018 | 774 | 301 | 183 | 256 | N/A |
9/30/2018 | 755 | 285 | 185 | 252 | N/A |
6/30/2018 | 748 | 279 | N/A | 210 | N/A |
3/31/2018 | 718 | 280 | N/A | 209 | N/A |
12/31/2017 | 694 | 273 | N/A | 208 | N/A |
9/30/2017 | 657 | 266 | N/A | 205 | N/A |
6/30/2017 | 660 | 259 | N/A | 251 | N/A |
3/31/2017 | 658 | 259 | N/A | 254 | N/A |
12/31/2016 | 667 | 272 | N/A | 243 | N/A |
9/30/2016 | 646 | 266 | N/A | 228 | N/A |
6/30/2016 | 595 | 259 | N/A | 145 | N/A |
3/31/2016 | 590 | 255 | N/A | 144 | N/A |
12/31/2015 | 566 | 245 | N/A | 143 | N/A |
9/30/2015 | 548 | 222 | N/A | 130 | N/A |
6/30/2015 | 543 | 218 | N/A | 165 | N/A |
3/31/2015 | 524 | 218 | N/A | 146 | N/A |
12/31/2014 | 508 | 211 | N/A | 157 | N/A |
9/30/2014 | 480 | 205 | N/A | 170 | N/A |
12/31/2013 | 445 | 181 | N/A | 147 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300406's forecast earnings growth (23.2% per year) is above the savings rate (2.8%).
Earnings vs Market: 300406's earnings (23.2% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 300406's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300406's revenue (19.8% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300406's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300406's Return on Equity is forecast to be low in 3 years time (15.6%).